FIM
VIVO

Freedom Investment Management’s Meridian Bioscience Inc VIVO Stock Holding History

Freedom Investment Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-7,278
Closed -$221K – 798
2022
Q2 		$221K Buy
+7,278
New +$197K 0.02% 662
2021
Q2 		– Sell
-12,109
Closed -$318K – 923
2021
Q1 		$318K Buy
12,109
+1,865
+18% +$44.3K 0.02% 655
2020
Q4 		$191K Sell
10,244
-4,902
-32% -$91.5K 0.02% 581
2020
Q3 		$257K Sell
15,146
-207
-1% -$4.02K 0.03% 449
2020
Q2 		$358K Buy
+15,353
New +$222K 0.04% 364
2019
Q3 		– Sell
-30,894
Closed -$367K – 746
2019
Q2 		$367K Buy
+30,894
New +$372K 0.03% 447
2019
Q1 		– Sell
-12,245
Closed -$213K – 807
2018
Q4 		$213K Sell
12,245
-4,988
-29% -$85.1K 0.02% 685
2018
Q3 		$268K Sell
17,233
-561
-3% -$8.7K 0.02% 745
2018
Q2 		$283K Buy
+17,794
New +$265K 0.02% 777
2017
Q4 		– Sell
-12,851
Closed -$184K – 1192
2017
Q3 		$184K Buy
+12,851
New +$184K 0.01% 1030
2017
Q2 		– Sell
-10,149
Closed -$140K – 1145
2017
Q1 		$140K Sell
10,149
-19,417
-66% -$272K 0.01% 1008
2016
Q4 		$523K Sell
29,566
-4,565
-13% -$80.2K 0.03% 469
2016
Q3 		$658K Buy
34,131
+2,791
+9% +$54.6K 0.04% 374
2016
Q2 		$611K Buy
31,340
+887
+3% +$17.4K 0.04% 357
2016
Q1 		$628K Buy
30,453
+15,559
+104% +$307K 0.05% 328
2015
Q4 		$306K Buy
+14,894
New +$286K 0.02% 551

Other funds holding VIVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Freedom Investment Management's VIVO Position: Q3 2022 in Review

Freedom Investment Management sold out of Meridian Bioscience Inc (VIVO) in Q3 2022, closing a stake of 7,278 shares — an estimated $221K sold.

Freedom Investment Management first reported a position in VIVO in Q4 2015 and held it in 16 quarters. The position peaked at $658K in Q3 2016. 203 funds tracked by Wall St. Rank hold VIVO as of Q3 2022.

  • Freedom Investment Management reported no remaining Meridian Bioscience Inc position as of Q3 2022 after selling out during the quarter.
  • Freedom Investment Management sold 7,278 Meridian Bioscience Inc shares in Q3 2022, an estimated $221K.
  • Freedom Investment Management first reported a position in Meridian Bioscience Inc in Q4 2015 and held it in 16 quarters.
  • Freedom Investment Management's Meridian Bioscience Inc position peaked at $658K in Q3 2016.
  • 203 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2022.

Based on Freedom Investment Management's 13F filing for Q3 2022, filed 24 Oct 2022.